PPG Industries, Inc. vs Repligen Corporation Common Stock — how do they compare? PPG Industries, Inc. trades at $104.91 (market cap $23.31B), while Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B). The key difference: PPG Industries, Inc. is far larger — about 2.1× Repligen Corporation Common Stock's market cap, and PPG Industries, Inc. pays a 2.82% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold PPG Industries, Inc. for 68 Days and Repligen Corporation Common Stock for 0 Days on average.
| PPG | RGEN | |
|---|---|---|
Market Cap | $23.31B | $11.31B |
Volume | 1,812,724 | 1,216,919 |
Sector | Basic Materials | Health |
52-Week High | $131.56 | $194.57 |
52-Week Low | $94.34 | $102.87 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | $29.18B | $11.20B |
Dividend Yield | 2.82% | — |
Signals from Pluang's Aura AI — not financial advice
PPG trades at $104.55, up 0.81% on the day, with a bearish technical outlook as moving averages and oscillators signal selling pressure. The stock shows solid fundamentals with a P/E of 15.05, net income margin of 9.57%, and ROE of 19.63%, though recent earnings have been mixed with Q2 2026 missing estimates. Recent news highlights margin pressures in the Automotive Refinish segment and upcoming Q3 2026 results on October 27.
The outlook is cautiously optimistic given analyst consensus of Buy with a $130.50 price target, implying significant upside. Risks include segment-specific weakness and macroeconomic headwinds, but strong cash flow and dividend payments support shareholder value. The stock presents a value opportunity if earnings stabilize and growth resumes.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →